Department of Dermatology, Faculty of Medicine, Islamic Azad University of Medical Sciences, Sari Branch, Sari, Iran.
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
J Cosmet Dermatol. 2021 Jul;20(7):2156-2159. doi: 10.1111/jocd.13841. Epub 2020 Nov 25.
Acute Generalized Exanthematous Pustulosis (AGEP)is a rare, severe skin reactionmainly caused by medications such as antibiotics, anti fungals, Calcium channel blockers and Anti malarias. Although it resolves spontaneously in most patients, systemic corticosteroids are neededin severe cases.
In order to determine the drug that is causing this condition, patch testing must be performed. Hydroxychloroquine is a medication that is used for the treatment of rheumatic and dermatologic conditions. And although it has been rarely seen to cause this reaction, we report a case of Hydroxychloroquine-induced (HCQ) AGEP which was confirmed by Patch testing.
A woman 49 years of age with an18 month history of mild, untreated Rheumatoid Arthritis experienced an acute episode of arthritis in her right elbow. Upon going to a rheumatologist, Prednisolone 5 mg BID and HCQ 200 mg daily were administered for a 30-day period. But after only 17 days of this treatment, the patient developed generalized erythema and painful pustular eruptions. Prednisolone dosage was changedto 7.5 mg per day andHCQ was discontinued one day afterthe appearance of eruptions. The diffuse erythema started improving a week after the patient's hospitalization.Considering the factthat our patient was receiving multiple potentially causative medications, patch testing was necessary to distinguish the drug responsible for this reaction.
After the patch testing was done, HCQ-induced AGEP was confirmed.
Patch testing is the gold standard of determining the responsible drug for an AGEP reaction. It should also be kept in mind that HCQ, although rarely, can cause this condition.
急性泛发性发疹性脓疱病(AGEP)是一种罕见的严重皮肤反应,主要由抗生素、抗真菌药、钙通道阻滞剂和抗疟药等药物引起。虽然大多数患者会自行缓解,但在严重情况下需要使用全身皮质类固醇。
为了确定引起这种情况的药物,必须进行斑贴试验。羟氯喹是一种用于治疗风湿和皮肤病的药物。虽然它很少引起这种反应,但我们报告了一例羟氯喹诱导的(HCQ)AGEP 病例,该病例通过斑贴试验得到证实。
一名 49 岁女性,患有 18 个月的轻度未经治疗的类风湿关节炎,右肘急性发作关节炎。在看风湿病医生时,给予泼尼松龙 5mg BID 和羟氯喹 200mg 每日治疗 30 天。但在这种治疗仅 17 天后,患者出现全身红斑和疼痛性脓疱疹。泼尼松龙剂量改为每天 7.5mg,HCQ 在出现皮疹后一天停用。弥漫性红斑在患者住院一周后开始改善。考虑到患者正在接受多种潜在的致病药物,需要进行斑贴试验以区分引起这种反应的药物。
进行斑贴试验后,证实了 HCQ 诱导的 AGEP。
斑贴试验是确定 AGEP 反应的责任药物的金标准。还应记住,尽管很少见,但 HCQ 也可能引起这种情况。